By Michael Li
China’s Ministry of Commerce and Ministry of Science and Technology announced temporary pre-export registration requirements on October 16, 2026 for technologies listed in an accompanying attachment. Announcement No. 48 also opened consultation on proposed changes to China’s prohibited and restricted technology export catalogue.
For overseas buyers, the immediate issue is whether the technology and transaction fall within the registration requirement. Contract signing and regulatory readiness should be assessed separately when establishing a delivery timetable.
The consultation covers 40 technology entries: 23 in artificial intelligence, five in biomedicine and 12 in photovoltaics. The consultation period runs from October 16 to November 15, 2026.
The temporary registration requirement applies from publication until the revised catalogue takes effect. It also covers exports that have begun but remain incomplete.
The announcement identifies transactions involving overseas transfers of technology ownership, licensing of domestic technology for overseas use, and changes placing domestic technology under overseas ownership or actual control.
Its scope should therefore be assessed against both the technical attachment and the structure of the transaction.
For transaction planning, buyers and suppliers should prepare a clear inventory of the proposed deliverables.
That inventory may include technical documentation, software, manufacturing knowledge, training materials and equipment-related information. The purpose is to give the technical and legal reviewers a consistent description of what will be transferred.
A contract review should then address:
Responsibility for determining the applicable regulatory requirements.
Information each party must provide.
Evidence required before a delivery milestone is treated as complete.
The treatment of delays, incomplete approvals and changes in scope.
These are transaction-management recommendations. They do not establish that every technology sale, licence or equipment shipment is covered by the temporary requirement.
Regulatory registration is only one issue that can affect cross-border delivery.
In a separate case from September 2024, a Shenzhen company requested customs protection concerning photovoltaic production equipment valued at RMB 10.79 million. The official case report describes the suspension of clearance and the involvement of a technical investigator in examining suspected patent infringement. It also records that the rights holder subsequently brought court proceedings.
This was a patent-protection matter, not an enforcement case under the October 2026 registration requirement. Its relevance is that delivery planning may involve distinct questions about regulatory compliance and third-party intellectual property rights.
Projects involving overseas patent applications may also require a separate assessment of China’s foreign-filing confidentiality review. That process should not be treated as interchangeable with technology export registration.
It should not be treated as evidence of the supplier’s chain of title. Ownership and authority to grant the agreed rights require separate due diligence.
For review purposes, a product name alone may be insufficient. The parties should identify the actual technology, documentation and other deliverables involved.
No. It concerns a separate patent dispute in 2024 and is included only to illustrate another potential delivery risk.
Businesses acquiring technology can use IPcrossark’s IP enquiry channel to discuss the patent, copyright or transfer-related aspects of a proposed transaction.
Provide the relevant rights records, proposed deliverables and jurisdictions. The service scope should be clarified separately from any specialist technology export-control assessment.
Fields marked * are required. We usually reply within one business day.
We will reply by email within one business day. This window will close automatically.
